Source: International Congress 2017 – Update on TB: latest news
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. Hoel (Bergen, Norway). IP-10 point-of-care tests for monitoring treatment efficacy in tuberculosis in a low-resource setting. 1950

Member's Comments

No comment yet.

Related content which might interest you: Point-of-care urine test for assessing adherence to isoniazid treatment for tuberculosis Source: Eur Respir J 2014; 43: 1519-1522 Year: 2014 IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting? Source: Eur Respir J 2012; 40: 161-168 Year: 2012 Assessing usability of QIAreach QuantiFERON-TB platform in a high tuberculosis prevalence, low-resource setting Source: ERJ Open Res, 7 (4) 00511-2021; 10.1183/23120541.00511-2021 Year: 2021 The effectiveness of the introduction of the updated treatment regimens and microbiological diagnostics MDR/XDR tuberculosis Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Improved diagnostic evaluation of suspected tuberculosis in routine practice Source: Annual Congress 2008 - New tools in tuberculosis diagnosis Year: 2008 Time frame sensitivity of a point-of-care test to monitor isoniazid adherence in TB treatment Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009 IGRA testing correlation with clinical and laboratory parameters in patients with tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Are in vitro sensitivity tests for tuberculosis drugs a good guide of clinical outcome? Source: Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level Year: 2006 The utility and choice of exercise testing in the evaluation of the efficacy of pulmonary rehabilitation Source: ERS Course 2017 Year: 2017 Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations Year: 2013 Are interferon- gamma release assays useful for diagnosing active tuberculosis in a high-burden setting? Source: Eur Respir J 2011; 38: 649-656 Year: 2011 Poor treatment outcomes of XDR-TB patients in resource-limited settings Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Use of molecular-genetic methods in diagnostics and therapy of a tuberculosis (TB) at patients with HIV Source: Annual Congress 2010 - Tuberculosis in special populations Year: 2010 Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10 Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease Year: 2008 Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study Source: Eur Respir J 2015; 46: 567-570 Year: 2015 Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test Source: Eur Respir J 2001; 18: Suppl. 33, 360s Year: 2001 Monitoring and evaluation of LTBI management Source: International Congress 2015 – Latent tuberculosis infection Year: 2015